Optimizing Management of Complicated Urinary Tract Infections: Access, Guidelines, and Emerging Oral Therapies
With complicated UTI driving over a million emergency visits and 100,000 hospitalizations annually, the panel opens by examining where costs concentrate and why moving patients off intravenous therapy remains one of the field's most persistent unmet needs.
Beyond the antibiotic itself, nursing time, staffing, and payer expectations shape whether a new complicated UTI therapy gains traction, with unmet need, safety, and demonstrated effectiveness forming the case any new agent must make.
